Form 8-K - Current report:
SEC Accession No. 0001437749-15-018022
Filing Date
2015-10-02
Accepted
2015-10-02 17:26:57
Documents
3
Period of Report
2015-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20151002_8k.htm 8-K 34608
2 EXHIBIT 5.1 ex5-1.htm EX-5.1 10908
3 EXHIBIT 10.1 ex10-1.htm EX-10.1 263667
  Complete submission text file 0001437749-15-018022.txt   310613
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 151141459
SIC: 2836 Biological Products, (No Diagnostic Substances)